Circulatory microRNAs are not effective biomarkers of muscle size and function in middle-aged men

Randall F D'Souza1, Nina Zeng1, Sally D Poppitt2,3

  • 1Liggins Institute, The University of Auckland , Auckland, New Zealand.

Insights

Circulating microRNAs (miRNAs) were assessed as biomarkers for muscle mass and strength in healthy men. While some plasma miRNAs correlated with muscle size, they did not reflect muscle expression levels, suggesting limited utility as direct biomarkers.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Gerontology

Background:

  • Muscle aging leads to morbidity, with current assessments relying on imaging and exercise tests.
  • Developing circulatory biomarkers for muscle phenotypes could simplify deficit identification.
  • MicroRNAs (miRNAs) regulate gene translation and influence muscle characteristics.

Purpose of the Study:

  • To evaluate the potential of circulating miRNAs (c-miRNAs) as biomarkers for muscular phenotypes.
  • To investigate the relationship between plasma miRNA expression and muscle mass/strength in middle-aged men.

Main Methods:

  • Fasting plasma and muscle samples were collected from 50 healthy middle-aged men.
  • RT-PCR was used to analyze the expression of 38 miRNAs in both plasma and muscle tissue.
  • Correlations were examined between miRNA levels and measures of total body lean mass, leg lean mass, thigh cross-sectional area (CSA), and knee extension torque.

Main Results:

  • Four c-miRNAs (miR-221, miR-451a, miR-361, miR-146a) correlated with muscle size parameters (lean mass, thigh CSA) but not strength.
  • No correlation was found between the expression of these c-miRNAs and their levels within muscle tissue.
  • Six muscle-specific miRNAs correlated with muscle mass, strength, or CSA.
  • Only miR-23b showed a weak link between tissue and circulatory expression, explaining only 10% of variance.
  • miR-146a showed relationships with phenotype in both plasma and muscle, but plasma and muscle expression levels were not correlated.

Conclusions:

  • Circulating miRNA biomarkers for muscle phenotypes appear largely unrelated to their expression within muscle tissue in healthy individuals.
  • The identified c-miRNAs may not be suitable direct biomarkers for muscle size or strength due to a lack of correlation with muscle expression.
  • Further research is needed to understand the complex relationship between circulating and tissue-specific miRNAs in muscle health and aging.

Related Concept Videos

Anatomy of the Circulatory System02:03

Anatomy of the Circulatory System

The human circulatory system consists of blood, blood vessels that carry blood away from the heart, around the body, and back to the heart, and the heart itself, which acts as a central pump. The systemic circuit supplies blood to the whole body, the coronary circuit supplies blood to the heart, and the pulmonary circuit supplies blood flow between the heart and lungs.
98.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
235
Functions of Smooth Muscles01:23

Functions of Smooth Muscles

Smooth muscles are an important type of muscle tissue that plays a vital role in the involuntary movements of internal organs. For example, they help regulate the movement of food through the gut and the flow of blood through the circulatory system.
Function of visceral smooth muscles
Visceral smooth muscle is found in the walls of all hollow organs, except the heart, and is a key player in the involuntary movements that drive the functioning of these internal organs. This tissue is arranged in...
3.4K
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.7K